Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis
Open Access
- 29 November 2023
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 121, 48-55
Abstract
No abstract availableKeywords
Funding Information
- Sanofi US
This publication has 27 references indexed in Scilit:
- ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Prophylaxis of venous thromboembolism in elderly patients with multimorbidityInternal and Emergency Medicine, 2013
- Prevention of VTE in Nonsurgical PatientsChest, 2012
- Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTEChest, 2011
- Factors at Admission Associated With Bleeding Risk in Medical PatientsChest, 2011
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsCirculation, 2004
- Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical IllnessArchives of internal medicine (1960), 2004
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999